Latest News

"Trillium to Commence Clinical Testing of TTI-1612 in Patients with Interstitial Cystitis/Bladder Pain Syndrome" go »

 
Trillium Therapeutics Inc. (TTI) is a private research and development biopharmaceutical company with two main areas of focus: cytoprotection and immune regulation.